Acurx Pharmaceuticals Inc (NASDAQ: ACXP) on Monday, plunged -5.31% from the previous trading day, before settling in for the closing price of $0.45. Within the past 52 weeks, ACXP’s price has moved between $0.30 and $2.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -7.84%. The company achieved an average annual earnings per share of 42.53%. With a float of $25.73 million, this company’s outstanding shares have now reached $29.63 million.
The extent of productivity of a business whose workforce counts for 4 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Acurx Pharmaceuticals Inc (ACXP) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Acurx Pharmaceuticals Inc is 13.17%, while institutional ownership is 11.95%. The most recent insider transaction that took place on Jan 06 ’25, was worth 25,000. In this transaction Director of this company bought 24,631 shares at a rate of $1.01, taking the stock ownership to the 27,708 shares. Before that another transaction happened on Jan 06 ’25, when Company’s Director bought 24,631 for $1.01, making the entire transaction worth $25,000. This insider now owns 137,183 shares in total.
Acurx Pharmaceuticals Inc (ACXP) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 42.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.59% during the next five years compared to -7.84% drop over the previous five years of trading.
Acurx Pharmaceuticals Inc (NASDAQ: ACXP) Trading Performance Indicators
Acurx Pharmaceuticals Inc (ACXP) is currently performing well based on its current performance indicators. A quick ratio of 1.93 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.70, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.51 in one year’s time.
Technical Analysis of Acurx Pharmaceuticals Inc (ACXP)
The latest stats from [Acurx Pharmaceuticals Inc, ACXP] show that its last 5-days average volume of 0.7 million was inferior to 3.03 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 22.37%.
During the past 100 days, Acurx Pharmaceuticals Inc’s (ACXP) raw stochastic average was set at 16.81%, which indicates a significant increase from 14.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0534 in the past 14 days, which was higher than the 0.0412 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4365, while its 200-day Moving Average is $0.8414.
